Use of both RD9 and IS6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplexcompliant IS6110 and RD9 targets

Details for Australian Patent Application No. 2005336287 (hide)

International Classifications

Event Publications

13 March 2008 PCT application entered the National Phase

PCT publication WO2007/028414 Priority application(s): WO2007/028414

1 October 2009 Amendment Made

The nature of the amendment is: Amend the name of the inventors to add co-inventor Savoye, Chantal 2006

25 August 2011 Alteration of Name

The name of the applicant has been altered to Bio-Rad Innovations 2006

2 February 2012 Application Accepted

Published as AU-B-2005336287

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.